Suchergebnisse - "van Tellingen, Olaf"

1

The effect of P-glycoprotein and cytochrome P450 3a on the oral bioavailability of vinorelbine in mice

von: Press, Rogier R.

2005, in: Cancer chemotherapy and pharmacology

Wird geladen...
2

The influence of the P-glycoprotein inhibitor zosuquidar trihydrochloride (LY335979) on the brain penetration of paclitaxel in mice

von: Kemper, E. Marleen

2003, in: Cancer chemotherapy and pharmacology

Wird geladen...
3

An Experimenter’s Guide to Glioblastoma Invasion Pathways

von: de Gooijer, Mark C.

2018transfer abstract, in: Ocean sand ridge signatures in the Bohai Sea observed by satellite ocean color and synthetic aperture radar measurements

Wird geladen...
4

ATP-binding cassette transporters limit the brain penetration of Wee1 inhibitors

von: de Gooijer, Mark C.

2017, in: Investigational new drugs

Wird geladen...
5

The vascular compartment hampers accurate determination of teniposide penetration into brain tumor tissue

von: van Tellingen, Olaf

1997, in: Cancer chemotherapy and pharmacology

Wird geladen...
6

The effect of P-gp (Mdr1a/1b), BCRP (Bcrp1) and P-gp/BCRP inhibitors on the in vivo absorption, distribution, metabolism and excretion of imatinib

von: Oostendorp, Roos L.

2008, in: Investigational new drugs

Wird geladen...
7

The Oral Route for the Administration of Cytotoxic Drugs: Strategies to Increase the Efficiency and Consistency of Drug Delivery

von: Bardelmeijer, Heleen A.

2000, in: Investigational new drugs

Wird geladen...
8

Entrapment by Cremophor EL decreases the absorption of paclitaxel from the gut

von: Bardelmeijer, Heleen A.

2001, in: Cancer chemotherapy and pharmacology

Wird geladen...
9

“Effect of the drug transporters ABCB1, ABCC2, and ABCG2 on the disposition and brain accumulation of the taxane analog BMS-275,183”

von: Marchetti, Serena

2014, in: Investigational new drugs

Wird geladen...
10

Restricted brain penetration of the tyrosine kinase inhibitor erlotinib due to the drug transporters P-gp and BCRP

von: de Vries, Nienke A.

2010, in: Investigational new drugs

Wird geladen...
11

Effect of the drug transporters ABCG2, Abcg2, ABCB1 and ABCC2 on the disposition, brain accumulation and myelotoxicity of the aurora kinase B inhibitor barasertib and its more active form barasertib-hydroxy-QPA

von: Marchetti, Serena

2013, in: Investigational new drugs

Wird geladen...
12

P-glycoprotein and breast cancer resistance protein restrict the brain penetration of the CDK4/6 inhibitor palbociclib

von: de Gooijer, Mark C.

2015, in: Investigational new drugs

Wird geladen...
13

Erratum to: Effect of the drug transporters ABCG2, Abcg2, ABCB1 and ABCC2 on the disposition, brain accumulation and myelotoxicity of the aurora kinase B inhibitor barasertib and its more active form barasertib-hydroxy-QPA

von: Marchetti, Serena

2013, in: Investigational new drugs

Wird geladen...
14

ATP-binding cassette transporter inhibitor potency and substrate drug affinity are critical determinants of successful drug delivery enhancement to the brain

von: Lentzas, Aristeidis

2024, in: Fluids and barriers of the CNS

Wird geladen...
15

Trabectedin (ET-743, Yondelis™) is a substrate for P-glycoprotein, but only high expression of P-glycoprotein confers the multidrug resistance phenotype

von: Beumer, Jan-Hendrik

2006, in: Investigational new drugs

Wird geladen...
16

Clinical pharmacokinetics of an amorphous solid dispersion tablet of elacridar

von: Sawicki, Emilia

2016, in: Drug Delivery and Translational Research

Wird geladen...
17

Retrospective analysis of serum testosterone levels by LC-MS/MS in chemically castrated prostate cancer patients: Biological variation and analytical performance specifications

von: van Winden, Lennart J.

2021, in: Li-CO

Wird geladen...
18

Concerns about anti-angiogenic treatment in patients with glioblastoma multiforme

von: Richel Dirk J

2009, in: BMC Cancer

Wird geladen...
19

Concerns about anti-angiogenic treatment in patients with glioblastoma multiforme

von: Verhoeff, Joost JC

2009, in: BMC cancer

Wird geladen...
20

Plasma membrane targeting by short chain sphingolipids inserted in liposomes improves anti-tumor activity of mitoxantrone in an orthotopic breast carcinoma xenograft model

von: Cordeiro Pedrosa, Lília R.

2015, in: Combat periarticular tibia injury outcome study (CAPTIOUS): risk factors for reoperation and amputation after open periarticular tibia fractures

Wird geladen...

Nicht das Richtige dabei?

Schreiben Sie uns!